Integra Lifesciences Holdings Corp IART
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holding Corporation - IART
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holding Corporation - IART
Integra LifeSciences to Highlight Hands-On Education and Neurosurgery Innovation at CNS 2026 Annual Meeting
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holding Corporation - IART
Lost Money on Integra LifeSciences Holdings Corporation Stock? Glancy Prongay Wolke & Rotter LLP Investigates Possible Securities Fraud After 21.2% Share Price Drop
Did You Lose Money on Integra LifeSciences Holdings Corporation Stock? The Law Offices of Howard G. Smith Announces Securities Fraud Investigation After 21.2% Share Price Decline
Lost Money on Integra LifeSciences Holdings Corporation Shares? The Law Offices of Frank R. Cruz Investigates Potential Securities Fraud After 21.2% Stock Decline
Integra LifeSciences Reports Third Quarter 2026 Financial Results
Trading Information
- Previous Close Price
- $13.55
- Day Range
- $13.16–13.79
- 52-Week Range
- $8.70–20.49
- Bid/Ask
- $12.30 / $13.92
- Shares Outstanding
- 77.80M
- Market Cap
- $1.03B
- Volume/Avg
- 828,616 / 1M
Key Statistics
- Price/Earnings (Normalized)
- 5.36
- Price/Sales
- 0.62
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 4,427
- Website
- https://www.integralife.com
Valuation
Metric | IART |
|---|---|
Price/Earnings (Normalized) | 5.36 |
Price/Book Value | 0.97 |
Price/Sales | 0.62 |
Price/Cash Flow | 5.87 |
Price/Earnings
IART
Financial Strength
Metric | IART |
|---|---|
Quick Ratio | 0.00 |
Current Ratio | 3.62 |
Interest Coverage | 1.05 |
Quick Ratio
IART
Profitability
Metric | IART |
|---|---|
Return on Assets (Normalized) | 0.82% |
Return on Equity (Normalized) | 2.80% |
Return on Invested Capital (Normalized) | 3.17% |
Return on Assets
IART
Medical Devices Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Abbott Laboratories ABT | LOCK|CVpcX&q | LOCK|r<@Pg | $178B | |||
| Medtronic PLC MDT | LOCK|^R!ccp> | LOCK|gcc>q | $128B | |||
| Stryker Corp SYK | LOCK|CN?>#tk | LOCK|$js | $118B | |||
| Boston Scientific Corp BSX | LOCK|d&>$?? | LOCK|WX^> | $61B | |||
| Edwards Lifesciences Corp EW | LOCK|@DR$RKp< | LOCK|v>d<^ | $59B | |||
| GE HealthCare Technologies Inc Common Stock GEHC | LOCK|Jzc<js> | LOCK|S^ | $36B | |||
| DexCom Inc DXCM | LOCK|t?wXDfV | LOCK|@zH@> | $30B | |||
| Koninklijke Philips NV ADR PHG | LOCK|!@@ | LOCK|PJP | $28B | |||
| Steris PLC STE | LOCK|!LD>Jx@ | LOCK|^@m# | $25B | |||
| Zimmer Biomet Holdings Inc ZBH | LOCK|!pn!&DH | LOCK|n&& | $19B |